POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization

POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization PR Newswire

GUANGZHOU, China, Sept. 30, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an update on the continued progress in the development and commercialization of its AI-enabled chronic disease management ecosystem, including further optimization of its proprietary AI chronic disease management system, expanded real-world data ("RWD") applications, and integrated in-hospital and out-of-hospital chronic disease management pilots.